Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929638-21-000959
Filing Date
2021-07-30
Accepted
2021-07-30 16:01:33
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE GP II, LLC

Document Format Files

Seq Description Document Type Size
1 cormorant_sc13d.htm SC 13D 102595
2 JOINT FILING AGREEMENT, BY AND AMONG THE REPORTING PERSONS. exhibit99-1.htm EX-99.1 10720
  Complete submission text file 0000929638-21-000959.txt   115170
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Subject) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92728 | Film No.: 211132396
SIC: 2834 Pharmaceutical Preparations